Bionano Genomics (BNGO) Other Non Operating Income (2018 - 2026)
Bionano Genomics (BNGO) posted Other Non Operating Income of -$619000.0 for Q1 2026, up 87.07% sequentially from -$4.8 million in Q4 2025, and down 112.19% YoY from $5.1 million in Q1 2025.
Bionano Genomics (BNGO) Other Non Operating Income (2018 - 2026) Analysis & Trends
Bionano Genomics has reported Other Non Operating Income for 9 years, with the latest figure at -$619000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 112.19% year-over-year to -$619000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.9 million (down 176.31% YoY) and the FY2025 annual result came in at $752000.0, up 1609.09% from the prior year.
- Other Non Operating Income grew to -$619000.0 in Q1 2026 per BNGO's latest filing, from -$4.8 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $5.1 million in Q1 2025 and troughed at -$20.2 million in Q4 2023.
- A 5-year average of -$1.2 million and a median of -$45000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income plunged 50307.5% in 2023, then soared 473.25% in 2025.
- Over 5 years, Other Non Operating Income stood at -$40000.0 in 2022, then slumped by 50307.5% to -$20.2 million in 2023, then jumped by 108.62% to $1.7 million in 2024, then tumbled by 375.37% to -$4.8 million in 2025, then jumped by 87.07% to -$619000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$619000.0, -$4.8 million, and -$219000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -344,000.00 |
| Mar 31, 2026 | -619,000.00 |
| Dec 31, 2025 | -4.79 Mn |
| Sep 30, 2025 | -219,000.00 |
| Jun 30, 2025 | 676,000.00 |
| Mar 31, 2025 | 5.08 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | -697,000.00 |
| Jun 30, 2024 | 363,000.00 |
| Mar 31, 2024 | -1.36 Mn |
| Dec 31, 2023 | -20.16 Mn |
| Sep 30, 2023 | -45,000.00 |
| Jun 30, 2023 | -330,000.00 |
| Mar 31, 2023 | 117,000.00 |
| Dec 31, 2022 | -40,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | -156,000.00 |
| Mar 31, 2022 | -33,000.00 |
| Dec 31, 2021 | -24,000.00 |
| Sep 30, 2021 | -67,000.00 |